266 related articles for article (PubMed ID: 31254845)
1. Cost-effectiveness of epileptic surgery compared with medical treatment in children with drug-resistant epilepsy.
Catchpool M; Dalziel K; Mahardya RTK; Harvey AS
Epilepsy Behav; 2019 Aug; 97():253-259. PubMed ID: 31254845
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of epilepsy surgery in children and adolescents with drug resistant focal epilepsy at three years in a tertiary care epilepsy center in Thailand.
Anurat K; Khongkhatithum C; Pattanaprateep O; Chamroonrat W; Boongird A; Visudtibhan A; Thampratankul L
J Clin Neurosci; 2020 Sep; 79():163-168. PubMed ID: 33070889
[TBL] [Abstract][Full Text] [Related]
3. An initial cost-effectiveness analysis of intraoperative magnetic resonance imaging (iMRI) in pediatric epilepsy surgery.
Sacino MF; Huang SS; Keating RF; Gaillard WD; Oluigbo CO
Childs Nerv Syst; 2018 Mar; 34(3):495-502. PubMed ID: 29159426
[TBL] [Abstract][Full Text] [Related]
4. Early economic evaluation of MRI-guided laser interstitial thermal therapy (MRgLITT) and epilepsy surgery for mesial temporal lobe epilepsy.
Widjaja E; Papastavros T; Sander B; Snead C; Pechlivanoglou P
PLoS One; 2019; 14(11):e0224571. PubMed ID: 31747402
[TBL] [Abstract][Full Text] [Related]
5. Costs and Clinical Outcomes of Epilepsy Surgery in Children With Drug-Resistant Epilepsy.
Oldham MS; Horn PS; Tsevat J; Standridge S
Pediatr Neurol; 2015 Sep; 53(3):216-20. PubMed ID: 26138748
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of pediatric epilepsy surgery compared to medical treatment in children with intractable epilepsy.
Widjaja E; Li B; Schinkel CD; Puchalski Ritchie L; Weaver J; Snead OC; Rutka JT; Coyte PC
Epilepsy Res; 2011 Mar; 94(1-2):61-8. PubMed ID: 21306874
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations.
Elliott J; McCoy B; Clifford T; Potter BK; Skidmore B; Wells GA; Coyle D
Syst Rev; 2019 Mar; 8(1):75. PubMed ID: 30917869
[TBL] [Abstract][Full Text] [Related]
8. [Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy--preliminary results].
Picot MC; Neveu D; Kahane P; Crespel A; Gélisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Rougier A; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Dujols P; Ryvlin P
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S354-67. PubMed ID: 15331984
[TBL] [Abstract][Full Text] [Related]
9. Cost-utility analysis of competing treatment strategies for drug-resistant epilepsy in children with Tuberous Sclerosis Complex.
Fallah A; Weil AG; Wang S; Lewis E; Baca CB; Mathern GW
Epilepsy Behav; 2016 Oct; 63():79-88. PubMed ID: 27591681
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcomes and economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy.
Wijnen BFM; de Kinderen RJA; Lambrechts DAJE; Postulart D; Aldenkamp AP; Majoie MHJM; Evers SMAA
Epilepsy Res; 2017 May; 132():91-99. PubMed ID: 28364726
[TBL] [Abstract][Full Text] [Related]
11. An economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy: An interim analysis.
de Kinderen RJ; Lambrechts DA; Wijnen BF; Postulart D; Aldenkamp AP; Majoie MH; Evers SM
Epilepsia; 2016 Jan; 57(1):41-50. PubMed ID: 26617284
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of epilepsy surgery in a controlled cohort of adult patients with intractable partial epilepsy: A 5-year follow-up study.
Picot MC; Jaussent A; Neveu D; Kahane P; Crespel A; Gelisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Macioce V; Dujols P; Ryvlin P
Epilepsia; 2016 Oct; 57(10):1669-1679. PubMed ID: 27595433
[TBL] [Abstract][Full Text] [Related]
13. The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.
Connock M; Frew E; Evans BW; Bryan S; Cummins C; Fry-Smith A; Li Wan Po A; Sandercock J
Health Technol Assess; 2006 Mar; 10(7):iii, ix-118. PubMed ID: 16545206
[TBL] [Abstract][Full Text] [Related]
14. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
15. Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.
Elliott J; van Katwyk S; McCoy B; Clifford T; Potter BK; Skidmore B; Wells GA; Coyle D
Pharmacoeconomics; 2019 Oct; 37(10):1261-1276. PubMed ID: 31201643
[TBL] [Abstract][Full Text] [Related]
16. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
[TBL] [Abstract][Full Text] [Related]
17. Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland.
Väätäinen S; Soini E; Peltola J; Charokopou M; Taiha M; Kälviäinen R
Adv Ther; 2020 Jan; 37(1):477-500. PubMed ID: 31808053
[TBL] [Abstract][Full Text] [Related]
18. Epilepsy care in ontario: an economic analysis of increasing access to epilepsy surgery.
Bowen JM; Snead OC; Chandra K; Blackhouse G; Goeree R
Ont Health Technol Assess Ser; 2012; 12(18):1-41. PubMed ID: 23074428
[TBL] [Abstract][Full Text] [Related]
19. The Effectiveness of Medical and Surgical Treatment for Children With Refractory Epilepsy.
Pan I; LoPresti MA; Clarke DF; Lam S
Neurosurgery; 2020 Dec; 88(1):E73-E82. PubMed ID: 32710761
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of surgical treatment compared to medical treatment in patients with drug-refractory epilepsy: A systematic review.
Kitschen A; Aleknonytė-Resch M; Sakalytė G; Diederich F
Eur J Neurol; 2023 Mar; 30(3):749-761. PubMed ID: 36371643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
